The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Complement Module, domain 1
".
FunFam 8: Complement receptor type 1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 29 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Complement component C3b binding GO:0001851
Interacting selectively and non-covalently with the C3b product of the complement cascade.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Complement component C4b binding GO:0001855
Interacting selectively and non-covalently with the C4b product of the classical complement cascade.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Complement component C4b receptor activity GO:0001861
Combining with the C4b product of the classical complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Complement component C3b receptor activity GO:0004877
Combining with the C3b product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Complement component C3b binding GO:0001851
Interacting selectively and non-covalently with the C3b product of the complement cascade.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Complement component C4b binding GO:0001855
Interacting selectively and non-covalently with the C4b product of the classical complement cascade.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Complement component C4b receptor activity GO:0001861
Combining with the C4b product of the classical complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Complement component C3b receptor activity GO:0004877
Combining with the C3b product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
10 | P04003 (/IPI) P08174 (/IPI) P19070 (/IPI) P19070 (/IPI) P19070 (/IPI) P20023 (/IPI) P20023 (/IPI) P20023 (/IPI) Q60736 (/IPI) Q60736 (/IPI) |
Complement binding GO:0001848
Interacting selectively and non-covalently with any component or product of the complement cascade.
|
3 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) |
Complement binding GO:0001848
Interacting selectively and non-covalently with any component or product of the complement cascade.
|
3 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
3 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
3 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) |
Enzyme inhibitor activity GO:0004857
Binds to and stops, prevents or reduces the activity of an enzyme.
|
3 | A0A0G2QC50 (/IDA) Q9Z0L9 (/IDA) Q9Z0M0 (/IDA) |
Complement receptor activity GO:0004875
Combining with any component or product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
3 | P19070 (/IMP) P19070 (/IMP) P19070 (/IMP) |
Complement receptor activity GO:0004875
Combining with any component or product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
3 | P20023 (/NAS) P20023 (/NAS) P20023 (/NAS) |
Complement receptor activity GO:0004875
Combining with any component or product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
3 | P20023 (/TAS) P20023 (/TAS) P20023 (/TAS) |
Transmembrane signaling receptor activity GO:0004888
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
|
3 | P20023 (/NAS) P20023 (/NAS) P20023 (/NAS) |
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
|
3 | P19070 (/IDA) P19070 (/IDA) P19070 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) |
Virus receptor activity GO:0001618
Combining with a virus component and mediating entry of the virus into the cell.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Enzyme inhibitor activity GO:0004857
Binds to and stops, prevents or reduces the activity of an enzyme.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Virus receptor activity GO:0001618
Combining with a virus component and mediating entry of the virus into the cell.
|
1 | P08174 (/IDA) |
Complement binding GO:0001848
Interacting selectively and non-covalently with any component or product of the complement cascade.
|
1 | Q63514 (/TAS) |
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
|
1 | P04003 (/HDA) |
Structural molecule activity GO:0005198
The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
|
1 | O08569 (/NAS) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
1 | P08174 (/IDA) |
There are 48 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of complement activation, alternative pathway GO:0045957
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the alternative pathway.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Negative regulation of complement activation, classical pathway GO:0045959
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Negative regulation of serine-type endopeptidase activity GO:1900004
Any process that stops, prevents or reduces the frequency, rate or extent of serine-type endopeptidase activity.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Positive regulation of serine-type endopeptidase activity GO:1900005
Any process that activates or increases the frequency, rate or extent of serine-type endopeptidase activity.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Regulation of complement activation GO:0030449
Any process that modulates the frequency, rate or extent of complement activation.
|
18 |
P04003 (/TAS)
P08174 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(8 more) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
13 |
P08174 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(3 more) |
Negative regulation of complement activation, classical pathway GO:0045959
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway.
|
13 |
P04003 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(3 more) |
Regulation of regulatory T cell differentiation GO:0045589
Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.
|
12 |
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(2 more) |
Negative regulation of complement activation, alternative pathway GO:0045957
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the alternative pathway.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Negative regulation of serine-type endopeptidase activity GO:1900004
Any process that stops, prevents or reduces the frequency, rate or extent of serine-type endopeptidase activity.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Positive regulation of serine-type endopeptidase activity GO:1900005
Any process that activates or increases the frequency, rate or extent of serine-type endopeptidase activity.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Regulation of complement activation GO:0030449
Any process that modulates the frequency, rate or extent of complement activation.
|
4 | P08174 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) |
Negative regulation of complement activation GO:0045916
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
|
4 | A0A0G2QC50 (/IDA) P08174 (/IDA) Q9Z0L9 (/IDA) Q9Z0M0 (/IDA) |
Negative regulation of complement activation GO:0045916
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
|
4 | P49457 (/ISS) Q60401 (/ISS) Q61475 (/ISS) Q61476 (/ISS) |
Regulation of complement-dependent cytotoxicity GO:1903659
Any process that modulates the frequency, rate or extent of complement-dependent cytotoxicity.
|
4 | P08174 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
3 | P20023 (/NAS) P20023 (/NAS) P20023 (/NAS) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
3 | A0A0G2QC50 (/IEP) Q9Z0L9 (/IEP) Q9Z0M0 (/IEP) |
Binding of sperm to zona pellucida GO:0007339
The process in which the sperm binds to the zona pellucida glycoprotein layer of the egg. The process begins with the attachment of the sperm plasma membrane to the zona pellucida and includes attachment of the acrosome inner membrane to the zona pellucida after the acrosomal reaction takes place.
|
3 | Q60736 (/IMP) Q60736 (/IMP) Q7TSY4 (/IMP) |
B cell differentiation GO:0030183
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
3 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) |
B cell differentiation GO:0030183
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
3 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) |
B cell proliferation GO:0042100
The expansion of a B cell population by cell division. Follows B cell activation.
|
3 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) |
B cell proliferation GO:0042100
The expansion of a B cell population by cell division. Follows B cell activation.
|
3 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) |
B cell activation GO:0042113
The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
3 | P19070 (/IMP) P19070 (/IMP) P19070 (/IMP) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
3 | A0A0G2QC50 (/IEP) Q9Z0L9 (/IEP) Q9Z0M0 (/IEP) |
Negative regulation of complement activation GO:0045916
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
|
3 | P08174 (/IMP) Q63135 (/IMP) Q64735 (/IMP) |
Maternal process involved in parturition GO:0060137
A reproductive process occurring in the mother that results in birth.
|
3 | A0A0G2QC50 (/IEP) Q9Z0L9 (/IEP) Q9Z0M0 (/IEP) |
Single fertilization GO:0007338
The union of male and female gametes to form a zygote.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Binding of sperm to zona pellucida GO:0007339
The process in which the sperm binds to the zona pellucida glycoprotein layer of the egg. The process begins with the attachment of the sperm plasma membrane to the zona pellucida and includes attachment of the acrosome inner membrane to the zona pellucida after the acrosomal reaction takes place.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Binding of sperm to zona pellucida GO:0007339
The process in which the sperm binds to the zona pellucida glycoprotein layer of the egg. The process begins with the attachment of the sperm plasma membrane to the zona pellucida and includes attachment of the acrosome inner membrane to the zona pellucida after the acrosomal reaction takes place.
|
2 | Q60736 (/ISO) Q60736 (/ISO) |
Regulation of complement activation GO:0030449
Any process that modulates the frequency, rate or extent of complement activation.
|
2 | Q61475 (/ISO) Q64735 (/ISO) |
Regulation of complement-dependent cytotoxicity GO:1903659
Any process that modulates the frequency, rate or extent of complement-dependent cytotoxicity.
|
2 | Q61475 (/ISO) Q64735 (/ISO) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
1 | Q64735 (/IGI) |
Endoplasmic reticulum to Golgi vesicle-mediated transport GO:0006888
The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
|
1 | P08174 (/TAS) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | Q63514 (/TAS) |
Organelle organization GO:0006996
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
|
1 | O08569 (/NAS) |
Positive regulation of cytosolic calcium ion concentration GO:0007204
Any process that increases the concentration of calcium ions in the cytosol.
|
1 | P08174 (/IDA) |
Acrosome reaction GO:0007340
The discharge, by sperm, of a single, anterior secretory granule following the sperm's attachment to the zona pellucida of the oocyte. The process begins with the fusion of the outer acrosomal membrane with the sperm plasma membrane and ends with the exocytosis of the acrosomal contents into the zona pellucida.
|
1 | O08569 (/NAS) |
Response to symbiotic bacterium GO:0009609
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a symbiotic bacterium, a bacterium living in close physical association with another organism.
|
1 | P04003 (/IDA) |
Regulation of complement activation GO:0030449
Any process that modulates the frequency, rate or extent of complement activation.
|
1 | Q64735 (/IMP) |
Regulation of complement activation, classical pathway GO:0030450
Any process that modulates the frequency, rate or extent of the classical pathway of complement activation.
|
1 | Q61475 (/IMP) |
Regulation of lipopolysaccharide-mediated signaling pathway GO:0031664
Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.
|
1 | P08174 (/IDA) |
CD4-positive, alpha-beta T cell cytokine production GO:0035743
Any process that contributes to cytokine production by a CD4-positive, alpha-beta T cell.
|
1 | P08174 (/IDA) |
Respiratory burst GO:0045730
A phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
|
1 | P08174 (/NAS) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
1 | P04003 (/IDA) |
Negative regulation of complement activation GO:0045916
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
|
1 | Q64735 (/ISO) |
Regulation of opsonization GO:1903027
Any process that modulates the frequency, rate or extent of opsonization.
|
1 | P04003 (/IDA) |
Positive regulation of CD4-positive, alpha-beta T cell activation GO:2000516
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
|
1 | P08174 (/IDA) |
Positive regulation of CD4-positive, alpha-beta T cell proliferation GO:2000563
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
|
1 | P08174 (/IDA) |
There are 35 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
29 |
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
F7D2W0 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
Q29528 (/ISS)
(19 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
17 |
P04003 (/TAS)
P08174 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(7 more) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
16 |
P08174 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
P17927 (/HDA)
(6 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
13 |
P08174 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(3 more) |
Secretory granule membrane GO:0030667
The lipid bilayer surrounding a secretory granule.
|
13 |
P08174 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(3 more) |
Ficolin-1-rich granule membrane GO:0101003
The lipid bilayer surrounding a ficolin-1-rich granule.
|
13 |
P08174 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
P17927 (/TAS)
(3 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
12 |
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
P17927 (/IDA)
(2 more) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
6 | P20023 (/IDA) P20023 (/IDA) P20023 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) Q2VPA4 (/IDA) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
5 | P19070 (/IDA) P19070 (/IDA) P19070 (/IDA) Q61475 (/IDA) Q64735 (/IDA) |
Acrosomal matrix GO:0043159
A structural framework, or 'dense core' at the interior of an acrosome. May regulate the distribution of hydrolases within the acrosome and their release during the acrosome reaction.
|
4 | O08569 (/IDA) Q60736 (/IDA) Q60736 (/IDA) Q7TSY4 (/IDA) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
4 | P19070 (/ISO) P19070 (/ISO) P19070 (/ISO) Q64735 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | P08174 (/IDA) Q60736 (/IDA) Q60736 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | P20023 (/NAS) P20023 (/NAS) P20023 (/NAS) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
3 | P20023 (/NAS) P20023 (/NAS) P20023 (/NAS) |
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
|
3 | A0A0G2QC50 (/IDA) Q9Z0L9 (/IDA) Q9Z0M0 (/IDA) |
Acrosomal vesicle GO:0001669
A structure in the head of a spermatozoon that contains acid hydrolases, and is concerned with the breakdown of the outer membrane of the ovum during fertilization. It lies just beneath the plasma membrane and is derived from the lysosome.
|
2 | Q60736 (/EXP) Q60736 (/EXP) |
Acrosomal vesicle GO:0001669
A structure in the head of a spermatozoon that contains acid hydrolases, and is concerned with the breakdown of the outer membrane of the ovum during fertilization. It lies just beneath the plasma membrane and is derived from the lysosome.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Outer acrosomal membrane GO:0002081
The acrosomal membrane region that underlies the plasma membrane of the sperm. This membrane fuses with the sperm plasma membrane as part of the acrosome reaction.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Zona pellucida receptor complex GO:0002199
A multisubunit complex comprising the chaperonin-containing T-complex and several other components involved in mediating sperm-oocyte Interaction.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Acrosomal matrix GO:0043159
A structural framework, or 'dense core' at the interior of an acrosome. May regulate the distribution of hydrolases within the acrosome and their release during the acrosome reaction.
|
2 | Q60736 (/ISO) Q60736 (/ISO) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
2 | Q60736 (/IDA) Q60736 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | Q61475 (/ISO) Q61476 (/ISO) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
1 | P08174 (/TAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | P04003 (/NAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | P08174 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P04003 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P04003 (/IDA) |
Transport vesicle GO:0030133
Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell.
|
1 | P08174 (/TAS) |
Endoplasmic reticulum-Golgi intermediate compartment membrane GO:0033116
The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.
|
1 | P08174 (/TAS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | P08174 (/IDA) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
1 | P04003 (/HDA) |